MilliporeSigma’s CTO on AI retrosynthesis, the Merck KGaA–Siemens deal and the chemistry that runs the autonomous lab
Over the past decade and a half, the Darmstadt-based Merck KGaA has assembled a supplier that touches nearly every bench in the lab. It bought Millipore in 2010, with the membrane filters and Milli-Q…
Read the full articleYou might also wanna read
Merck KGaA acquires Bio-Techne in $11 billion all-cash deal to bolster life sciences division
All-cash deal will strengthen the German company’s life sciences portfolio
cen.acs.org·12d agoGermany’s Merck Pumps Up Life Sciences Biz with $11.3B Bio-Techne Deal
Merck KGaA's agreement to buy Bio-Techne for $11.3 billion strengthens its hold in life sciences, especially drug discovery and gene therapy
Germany’s Merck to Buy Bio-Techne for $11.3 Billion
The all-cash deal gives Merck KGaA several new spatial technologies, including Lunaphore, along with Bio-Techne's antibody portfolio and oth
Christian Hackenberger on Tubulis: From academic startup to multibillion-dollar biotech acquisition
Christian Hackenberger talks to C&EN about the story behind Tubulis and what his Berlin-based lab is working on next
cen.acs.org·1mo ago
AI Retrosynthesis Tools: How Machines Plan Chemical Reactions in 2026
Learn how modern AI retrosynthesis tools utilize MCTS and deep learning to plan chemical pathways, and how ChemCopilot integrates them with
Berlin AI startup Kyrok raises €3.1M for pharma and chemical supply chain platform
Berlin-based industrial AI startup Kyrok has raised €3.1 million in a pre-seed round led by Speedinvest. The company is building an AI opera
tech.eu·16d ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.